HIV and COVID with Annie Antar, MD, PhD

Barriers to HIV screening in people who inject drugs and the impact of improved access to harm reduction services.

STI prevention strategies that should be offered to MSM as part of routine sexual health care.

Different HIV testing options and the potential benefits and limitations of HIV self-testing strategies.

The five "M's" of geriatrics and incorporating them into HIV care.

Take our post-test to claim CME credits. To read a companion newsletter click here. In the US, among women at high risk for acquiring HIV infection, only around 2% have initiated PrEP.  What are the patient, provider,

Take our post-test to claim CME credits. To read a companion newsletter click here. People who inject drugs (PWID) are at risk for HIV infection from both sexual- as well as injection-related causes. What can clinicians do to reduce the incidence of in...

In her recent newsletter issue (eHIV Review V5 #1), Dr. Ethel Weld, Assistant Professor of Medicine, Pharmacology and Molecular Sciences at the Johns Hopkins School of Medicine, analyzed the current research about the potential uses of two-drug ART reg...

Volume 4, Issue 12 “U=U” — an Undetectable HIV viral load means Untransmittable HIV virus.  In her recent eHIV Newsletter Issue (Vol. 4; No. 11), Dr. Jill Blumenthal from the Division of Infectious Diseases and Global Public Health at the University of...

Volume 4, Issue 10 In this Issue, Dr. Joyce Jones from the Johns Hopkins University School of Medicine and Dr. Barbara Taylor from the University of Texas Health Science Center at San Antonio analyze recent publications describing evidence-based ART ad...